Literature DB >> 20824532

Mechanisms of skeletal muscle weakness.

Håkan Westerblad1, Nicolas Place, Takashi Yamada.   

Abstract

Skeletal muscle weakness is an important feature of numerous -pathological conditions and it may also be a component in normal ageing. Decreased muscular strength can be due to decreased muscle mass and/or intrinsic defects in the muscle cells. In this chapter we will discuss decreased force production due to mechanisms intrinsic to skeletal muscle cells. We will mainly use data from mouse disease models to exemplify defects at various sites in the cellular activation-contraction pathway. We will show that depending on the underlying problem, muscle weakness can be due decreased Ca²(+) release from the sarcoplasmic reticulum, reduced myofibrillar Ca²(+) sensitivity and/or decreased ability of the cross-bridges to generate force.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824532     DOI: 10.1007/978-1-4419-6366-6_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Katherine Halievski; Laura Vicente; Youfen Xu; Donald Zeolla; Jessica Poort; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

2.  Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications.

Authors:  Sudhakar Veeranki; Lee J Winchester; Suresh C Tyagi
Journal:  Biochim Biophys Acta       Date:  2015-01-20

3.  Impact of a submaximal mono-articular exercise on the skeletal muscle function of patients with sickle cell disease.

Authors:  Etienne Gouraud; Philippe Connes; Alexandra Gauthier-Vasserot; Camille Faes; Salima Merazga; Solène Poutrel; Céline Renoux; Camille Boisson; Philippe Joly; Yves Bertrand; Arnaud Hot; Giovanna Cannas; Christophe Hautier
Journal:  Eur J Appl Physiol       Date:  2021-05-22       Impact factor: 3.078

4.  The Ca2+ sensitizer CK-2066260 increases myofibrillar Ca2+ sensitivity and submaximal force selectively in fast skeletal muscle.

Authors:  Darren T Hwee; Arthur J Cheng; James J Hartman; Aaron C Hinken; Ken Lee; Nickie Durham; Alan J Russell; Fady I Malik; Håkan Westerblad; Jeffrey R Jasper
Journal:  J Physiol       Date:  2017-01-24       Impact factor: 5.182

5.  Myostatin dysfunction does not protect from fasting-induced loss of muscle mass in mice.

Authors:  Andrej Fokin; Petras Minderis; Tomas Venckunas; Arimantas Lionikas; Mindaugas Kvedaras; Aivaras Ratkevicius
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-09-01       Impact factor: 2.041

6.  Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial.

Authors:  Mathilde Mura; Emeraude Rivoire; Leila Dehina-Khenniche; Michèle Weiss-Gayet; Bénédicte Chazaud; Camille Faes; Philippe Connes; Anne Long; Chantal L Rytz; Pauline Mury; Lidia Delrieu; Etienne Gouraud; Marine Bordet; Nellie Della Schiava; Patrick Lermusiaux; Matthieu Arsicot; Antoine Millon; Vincent Pialoux
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.728

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.